Exosomes Digest (3/4 May 2025)

May 24, 2025

We have collected the most exciting new researches in the field of genetics and cellular research in the past week.

Dual role of miR-155 and exosomal miR-155 in tumor angiogenesis: implications for cancer progression and therapy

Tumor angiogenesis facilitates cancer progression by supporting tumor growth and metastasis. MicroRNA-155 (miR-155) plays a pivotal role in regulating angiogenesis through both direct effects on tumor and endothelial cells and indirect modulation via exosomal communication. This review highlights miR-155’s pro-angiogenic influence on endothelial cell behavior and tumor microenvironment remodeling. Additionally, exosomal miR-155 enhances intercellular communication, promoting vascularization in several cancers. Emerging therapeutic strategies include miR-155 inhibition using antagomirs, exosome-mediated delivery systems, and modulation of pathways such as JAK2/STAT3 and TGF-β/SMAD2. Targeting miR-155 represents a promising approach to hinder tumor angiogenesis and improve cancer therapy outcomes.

Read full article

New ISO Certification

🏆 We’re proud to share that Vita Motus AG has once again been awarded the ISO

Exosomes Digest (4/4 August 2025)

We have collected the most exciting new research in the field of genetics and cellular reserach.

Thank you ISEV 2025!

We attended ISEV 2025, one of the world’s leading conferences focused on extracellular vesicles. It was